AOD-9604
Sourcing GuideQuality control discipline for AOD-9604 extends across procurement, storage, reconstitution, and use. Lyophilised vial inspection, COA cross-reference against lot, 1815.1 Da mass spec confirmation, and HPLC purity above 98% are the procurement layer; the storage and reconstitution layer is examined below.
Key Takeaways
Procurement lens: AOD-9604 sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 1815.1 Da. Mechanism: Mimics the C-terminal of human growth hormone (residues 176-191) to stimulate lipolysis and inhibit lipogenesis via β3-adrenergic-like signalling, without engaging the GH receptor or driving IGF-1 elevation. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
For procurement of AOD-9604, the relevant QC framework covers analytical purity (HPLC), structural identity (mass spec), microbiological safety (endotoxin), and stoichiometric correctness where applicable. Mimics the C-terminal of human growth hormone (residues 176-191) to stimulate lipolysis and inhibit lipogenesis via β3-adrenergic-like signalling, without engaging the GH receptor or driving IGF-1 elevation. The subsections below address each QC layer and the vendor-tier landscape.
COA evaluation and red flags
Acceptable AOD-9604 certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.
Vendor tier comparison and price discipline
Three vendor tiers operate in the AOD-9604 market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
Reconstitution and storage protocols
AOD-9604 is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
Sourcing AOD-9604 for storage protocol use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
Pharmaceutical-grade compounded AOD-9604 is the lowest-risk sourcing path for vial inspection use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
For users targeting lyophilisation quality, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Sourcing AOD-9604 for cold chain use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 300-500 mcg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 180-500 mcg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 300-500 mcg | 1x daily AM |
| Maintenance phase | SubQ | 210-500 mcg | Ongoing with periodic pauses |
Dose timing for AOD-9604 is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses. Fasted dosing produces stronger GH pulses; meal-paired dosing blunts the response.
AOD-9604 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- AOD-9604 + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with AOD-9604's mechanism in sourcing / quality / procurement protocols.
- AOD-9604 + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with AOD-9604's mechanism in sourcing / quality / procurement protocols.
- AOD-9604 + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with AOD-9604's mechanism in sourcing / quality / procurement protocols.
- AOD-9604 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with AOD-9604's mechanism in sourcing / quality / procurement protocols.
No significant elevation of IGF-1, glucose, or insulin in trials. Generally well tolerated. Pregnancy/lactation: avoid (no data).
Lens-specific safety considerations for sourcing / quality / procurement use of AOD-9604: No significant elevation of IGF-1, glucose, or insulin in trials. Generally well tolerated. Pregnancy/lactation: avoid (no data). Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| AOD-9604 | GH fragment | ~30 min IV; longer SubQ | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Lot variability across orders?
Storage protocol?
Vendor red flags?
Reconstitution best practices?
What is the regulatory status of AOD-9604?
What route should I use for AOD-9604?
Start a AOD-9604 Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified AOD-9604 and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- 1815.1 Da
- Sequence length
- 16 aa
- Half-life
- ~30 min IV; longer SubQ
- WADA
- Not on prohibited list (verify annually)
- FDA
- Unapproved (Research Only)
- Research
- Phase IIb completed; not commercialised
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for AOD-9604 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for AOD-9604
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised